Scientists have discovered a compound in python blood that reduces appetite and could lead to safer, more effective weight-loss drugs.

In a move clearly designed to strengthen its position among developers, OpenAI has acquired Python tool maker Astral. The house of Altman expects the deal to strengthen the ecosystem for its Codex ...

OpenAI announced Thursday that it has entered into an agreement to acquire Astral, the company behind popular open source Python development tools such as uv, Ruff, and ty, and integrate the company ...

Python is now one of the fastest-growing programming languages being used globally and supports machine-learning-based ...

A reticulated python has already completed its hunt of this small deer and is in the process of constricting its prey.

OpenAI to acquire Astral, bringing Python tools like uv, Ruff, and ty into Codex as it moves from code generation to executing full developer workflows.

OpenAI acquires Astral, the Python toolmaker, to enhance Codex AI coding assistant as it competes with Anthropic's Claude Code and Cursor.

OpenAI on Thursday announced the acquisition of Astral, the developer of open source Python tools that include uv, Ruff and ty. It says that it plans to integrate them with Codex, its AI coding agent ...

Metabolites from python blood have the potential to lead to the creation of weight-loss medications similar to Ozempic, according to new research. At first, scientists at Stanford University, Baylor ...

Rob Rausch of Peacock's 'The Traitors' and 'Love Island USA' demonstrates the chest and back workout he uses to stay in shape ...

Google revamps AI Studio into a full “vibe coding” platform with Firebase integration, as OpenAI races toward a unified AI superapp future.